I hope C4 therapeutics does many families well. I'm a strong believer in hoping for the best and planning for the worst. If things do not go as well with C4, then plan "B" is in order. I've been using this formula for years and it's proven well. I would highly recommend it to your children and their generations to come.
You should be learning to trade nasdaq and nyse stocks more efficiently with age to continually increase your income. Otc, forex and others are too full of misconceptions for me to recommend touching. It's important to understand the difference between risk management vs. riskless management. Risk management implies "how much money are you willing to lose". Whereas riskless management entails making very conservative decisions. When you do well making very conservative decisions, you will see there is simply no rational in taking unnecessary risks. When 25% of your monthly profits becomes enough to cover all your monthly expenses, then you can retire. The reason I say 25% is you must leave most(75%) in your account to ensure strong growth as well as ensure your short term capital gains taxes will always be there at tax time. With this formula the dollar amount of your monthly expense income(25% of your profits) will increase every month for the rest of your life to live very comfortably and take very well care of your family. The principle will have such strong growth that it will make a very good trust fund to help causes inwhich you truly believe in. A directive order in your trust fund to ensure taxes are accounted for should you pass will take the tax liability off of your family. Good luck to all and I hope this formula helps others as it has done for me. Perhaps one day skydiving at 104 years old will become the norm. Until then, bless this wonderful true lady for being an inspiring pioneer at 104.
You should be learning to trade nasdaq and nyse stocks more efficiently with age to continually increase your income. Otc, forex and others are too full of misconceptions for me to recommend touching. It's important to understand the difference between risk management vs. riskless management. Risk management implies "how much money are you willing to lose". Whereas riskless management entails making very conservative decisions. When you do well making very conservative decisions, you will see there is simply no rational in taking unnecessary risks. When 25% of your monthly profits becomes enough to cover all your monthly expenses, then you can retire. The reason I say 25% is you must leave most(75%) in your account to ensure strong growth as well as ensure your short term capital gains taxes will always be there at tax time. With this formula the dollar amount of your monthly expense income(25% of your profits) will increase every month for the rest of your life to live very comfortably and take very well care of your family. The principle will have such strong growth that it will make a very good trust fund to help causes inwhich you truly believe in. A directive order in your trust fund to ensure taxes are accounted for should you pass will take the tax liability off of your family. Good luck to all and I hope this formula helps others as it has done for me. Perhaps one day skydiving at 104 years old will become the norm. Until then, bless this wonderful true lady for being an inspiring pioneer at 104.
You have the patience the strength and the passion
To achieve your ambitions your goals and your dreams.
All you need to do is try!
Recent CCCC News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 11:17:23 AM
- C4 Therapeutics shares jump on expanded oncology collaboration with Roche • IH Market News • 04/09/2026 02:57:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 11:07:35 AM
- C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs) • GlobeNewswire Inc. • 04/09/2026 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 02:45:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 02:45:44 PM
- C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma • GlobeNewswire Inc. • 03/25/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/09/2026 08:20:02 PM
- C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/09/2026 08:01:00 PM
- Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types • PR Newswire (Canada) • 03/05/2026 02:00:00 PM
- Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types • PR Newswire (US) • 03/05/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:49:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:09:49 PM
- C4 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/26/2026 12:00:00 PM
- C4 Therapeutics to Participate in Upcoming March Conferences • GlobeNewswire Inc. • 02/23/2026 12:10:00 PM
- C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma • GlobeNewswire Inc. • 02/23/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 10:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 10:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 10:05:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 10:04:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 10:04:38 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 06:45:15 PM
- C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/09/2026 09:01:00 PM
- C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:00:00 PM
